Sotabase

Career

· Postdoctoral Researcher, MIT FutureTech2025–
· PhD in Economics, Barcelona School of Economics
· B.S. in Business Management, Fairleigh Dickinson University
· Merck & Co., Inc.
· PhD in Economics, Universitat Autònoma de Barcelona

Publications (52)

Worsening renal function in acute heart failure in the context of diuretic response
European Journal of Heart Failure · 2021
64
cited
Albuminuria as a marker of systemic congestion in patients with heart failure
European Heart Journal · 2022
51
cited
Clinical value of pre‐discharge bio‐adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission
European Journal of Heart Failure · 2019
47
cited
The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
Clinical Research in Cardiology · 2019
45
cited
Plasma kidney injury molecule‐1 in heart failure: renal mechanisms and clinical outcome
European Journal of Heart Failure · 2016
43
cited
Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure.
Circulation: Heart Failure · 2019
33
cited
Proteomic diversity of high‐density lipoprotein explains its association with clinical outcome in patients with heart failure
European Journal of Heart Failure · 2018
32
cited
Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure.
Journal of the American College of Cardiology · 2023
29
cited
Sex-specific risk factors for new-onset heart failure: the PREVEND study at 25 years
European Heart Journal · 2024
28
cited
Heart failure with improved versus persistently reduced left ventricular ejection fraction: A comparison of the BIOSTAT‐CHF (European) study with the ASIAN‐HF registry
European Journal of Heart Failure · 2024
19
cited
Impaired High‐Density Lipoprotein Function in Patients With Heart Failure
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · 2020
18
cited
Sex disparities in the effect of statins on lipid parameters
Medicine · 2022
16
cited
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome
European Journal of Heart Failure · 2023
14
cited
Assessment of Proximal Tubular Function by Tubular Maximum Phosphate Reabsorption Capacity in Heart Failure
American Society of Nephrology. Clinical Journal · 2022
11
cited
Proenkephalin and the risk of new‐onset heart failure: data from prevention of renal and vascular end‐stage disease
Clinical Cardiology · 2021
9
cited
Systemic oxidative stress associates with disease severity and outcome in patients with new-onset or worsening heart failure
Clinical Research in Cardiology · 2023
9
cited
Are circulating relaxin levels related to pulmonary hypertension in patients with heart failure?
European Journal of Heart Failure · 2017
4
cited
Association between antecedent myocardial infarction and heart failure with preserved versus reduced ejection fraction
European Journal of Heart Failure · 2025
2
cited
Association between adherence to statin therapy and low-density lipoprotein cholesterol (LDL-c) response in first-time users of standard-dose and low-dose statins: the PharmLines initiative
Current Medical Research and Opinion · 2021
1
cited
Biomarker profiles and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome
European Heart Journal · 2022
Sotabase